Newborn Brain Test (NBT)
NBT
NBT
Sponsor study identifier
observational
93
1 country
1
Study Start
July 22, 2024
Actual (reported)Primary Completion
January 29, 2025
Actual (reported)Study Completion
February 4, 2025
Actual (reported)The aim of the overall project is to develop the Newborn Brain Test (NBT), a novel platform to detect abnormal brain activity in infants at birth through an automated AI assessment. Easy to interpret results, provided in less than 15 minutes, will allow for immediate follow up by a medical team when abnormal brain function is detected. NBT has been developed by INFANT's study partner CergenX (UCC Spinout company), who sponsors the study. INFANT is responsible for the clinical aspect of the project and will conduct a feasibility study of the device as well as a larger pivotal investigation.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
February 4, 2025
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
July 22, 2024
Actual (reported)July 24, 2024
Actual (reported)August 30, 2024
Actual (reported)January 29, 2025
Actual (reported)February 4, 2025
Actual (reported)Assessing whether an acceptable EEG recording can be attained for the device on the first attempt for 80% of attempted recordings
Feasibility of the device is achieved if a good quality recording on the first attempt is achieved in at least 80% of infants , i.e. the device is not feasible if the success rate is \<80%. Acceptable EEG in terms of technical quality for satisfactory review: * The recording should clearly be recording brain activity; if an electrode is poorly attached or detached, the EEG channel is likely to show continuous high amplitude/chaotic artifact which is not acceptable. * The brain activity for a term baby should contain continuous activity of mixed frequency content (delta, theta, alpha activity) with amplitudes ranging from 25-150µV. * The EEG should not be marred by persistent 50Hz due to high electrode impedance, that makes the recording unreadable. A 'majority' (50%+) of the EEG should be artefact free and readable.
Day 1
Time taken to complete assessment (as above) when a good quality recording is obtained for an infant on the first attempt
Day 1
Time taken to complete assessment (as above) when a good quality recording is NOT obtained for an infant on the first attempt.
Day 1
Number of attempts by a user before a good quality recording is achieved (Max 3 attempts)
Day 1
Assessment of healthcare satisfaction with useability of the device and procedure derived from data captured during recordings and interviews.
The interviews will be conducted with the researchers after 10 weeks, after 20 weeks and at the end of the study - up to 30 weeks
50% of the babies recruited will be from the Neonatal Intensive Care Unit. All term neonates ≥ 37 and ≤ 45 weeks corrected gestation age are eligible for the NBT study that do not have head trauma or broken skin on the scalp.
50% of the babies recruited will be from the Post Natal Ward. All term neonates ≥ 37 and ≤ 45 weeks corrected gestation age are eligible for the NBT study that do not have head trauma or broken skin on the scalp.
Short EEG recording using EEG amplifier with cloud based algorithm to assess brain injury.
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
90 babies will be recruited in total that meet the inclusion criteria above. 45 will be from the Neonatal Intensive care Unit and 45 from the Post natal Ward
Cork University Maternity Hospital
Cork, T12 YE02, Ireland
Geraldine Boylan, Professor
University College Cork INFANT Centre
93 participants (actual enrollment reported by the registry).
First Submitted
July 24, 2024
First Posted
August 30, 2024
Study Start
July 22, 2024
Actual (reported)Lariboisière Cognitive Assessment: Evaluation of the 1-year Outcomes
Contact the study team to confirm eligibility.
Primary Completion
January 29, 2025
Actual (reported)Study Completion
February 4, 2025
Actual (reported)Last Updated
April 9, 2025
Record last verified: 2025-04
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: